Elizabeth L. Hougen
2017
In 2017, Elizabeth L. Hougen earned a total compensation of $2.2M as Senior Vice President, Finance and Chief Financial Officer at Ionis Pharmaceuticals, a 5% increase compared to previous year.
Compensation breakdown
| Bonus | $264,064 |
|---|---|
| Option Awards | $1,141,147 |
| Salary | $425,224 |
| Stock Awards | $362,454 |
| Other | $38,887 |
| Total | $2,231,776 |
Hougen received $1.1M in option awards, accounting for 51% of the total pay in 2017.
Hougen also received $264.1K in bonus, $425.2K in salary, $362.5K in stock awards and $38.9K in other compensation.
Rankings
In 2017, Elizabeth L. Hougen's compensation ranked 4,981st out of 14,666 executives tracked by ExecPay. In other words, Hougen earned more than 66.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,981 out of 14,666 | 66th |
Division Manufacturing | 1,772 out of 5,772 | 69th |
Major group Chemicals And Allied Products | 524 out of 2,075 | 75th |
Industry group Drugs | 404 out of 1,731 | 77th |
Industry Pharmaceutical Preparations | 321 out of 1,333 | 76th |
Source: SEC filing on April 26, 2019.
Hougen's colleagues
We found five more compensation records of executives who worked with Elizabeth L. Hougen at Ionis Pharmaceuticals in 2017.
2017
Stanley Crooke
Ionis Pharmaceuticals
Chief Executive Officer
2017
B Parshall
Ionis Pharmaceuticals
Chief Operating Officer
2017
Brett Monia
Ionis Pharmaceuticals
Chief Operating Officer
2017
Richard Geary
Ionis Pharmaceuticals
Senior Vice President, Development
2017
Patrick O'Neil
Ionis Pharmaceuticals